Politics
GLP-1s may work by activating an unlikely weight loss ally
The Hill·September 1, 2026·1 min read
A new study suggests GLP-1 drugs may work by activating hunger neurons, not just suppressing appetite. Testing in living humans isn't possible, but researchers hope the data guides new weight loss treatments. The findings could reshape understanding of obesity therapies.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.